![]() |
市場調查報告書
商品編碼
1544653
玻璃化市場、機會、成長動力、產業趨勢分析與預測,2024-2032Vitrification Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
在不孕率不斷上升的推動下,玻璃化冷凍市場規模從 2024 年到 2032 年的複合年成長率預計將達到 10.1%。玻璃化冷凍是保存胚胎和卵母細胞的關鍵技術,可以保護那些面臨生育問題的人的生殖選擇。為了滿足生育治療不斷成長的需求,研究人員和臨床醫生正在對玻璃化冷凍過程進行微調。這些增強功能不僅提高了生育手術的成功率,也為面臨不孕症挑戰的個人提供了強而有力的支持。根據世界衛生組織最近的報告,全球約有六分之一的人患有不孕症。這種上升趨勢正在推動玻璃化冷凍方法的採用,旨在提高輔助生殖治療的成功率。
玻璃化產業分為產品類型、樣本、最終用途和地區。
試劑盒產品類型細分市場的市場佔有率將在2024 年至2032 年間錄得可觀的成長率。 。這種快速冷卻可以最大限度地減少冰的形成,而冰的形成是細胞和組織活力的關鍵因素。玻璃化試劑盒在幹細胞儲存和胚胎保存等應用中也發揮關鍵作用,可微調冷卻速率和配方以提高保存成功率。
就標本而言,預計 2024 年至 2032 年胚胎玻璃化市場將出現顯著的複合年成長率。這種生長是由保存胚胎、抑製冰晶形成和潛在細胞損傷的必要性所驅動的。隨著玻璃化冷凍方案的不斷完善,研究人員的目標是提高胚胎保存和植入的成功率。這些進步有望提供更有效、更可靠的胚胎保存方法,與生育治療和生殖健康的發展保持一致。
由於政府措施和資金的增加,到 2032 年,亞太地區玻璃化產業規模將創下顯著的複合年成長率。許多政府都支持冷凍保存技術研究,包括玻璃化冷凍,以促進生育治療和生殖健康。這些措施旨在利用財政援助和資源來提高技術及其成功率。這種堅定不移的支持凸顯了玻璃化冷凍在推動亞太地區生殖保健方面的關鍵作用。
Vitrification Market size is set to record a 10.1% CAGR from 2024 to 2032 driven by escalating infertility rates. Vitrification serves as a pivotal technique for preserving embryos and oocytes for safeguarding reproductive choices for those grappling with fertility issues. In response to the surging demand for fertility treatments, researchers and clinicians are fine-tuning the vitrification process. These enhancements not only bolster the success rates of fertility procedures but also offer robust support to individuals facing infertility challenges. According to a recent WHO report, approximately 1 in 6 individuals globally contend with infertility. This rising trend is propelling the adoption of vitrification methods, aiming to boost success rates in assisted reproductive treatments.
The vitrification industry is segmented into product type, specimen, end-use, and region.
The market share from the kits product type segment will record a decent growth rate between 2024 and 2032. This surge is attributed to the increasing demand for biological sample preservation, achieved by swiftly cooling samples to a glass-like state. Such rapid cooling minimizes ice formation, a crucial factor for the viability of cells and tissues. Vitrification kits also play a pivotal role in applications like stem cell storage and embryo preservation for fine-tuning cooling rates and formulations to enhance preservation success rates.
In terms of specimen, the vitrification market from the embryos segment is anticipated to witness a significant CAGR from 2024-2032. This growth is driven by the imperative to preserve embryos, curbing ice crystal formation and potential cell damage. With ongoing refinements in vitrification protocols, researchers aim to boost embryo preservation and implantation success rates. These advancements promise more effective and dependable embryo preservation methods, aligning with the evolution of fertility treatments and reproductive health.
Asia Pacific vitrification industry size will record a significant CAGR through 2032 due to rising government initiatives and funding. Numerous governments are backing cryopreservation technology research, including vitrification, to bolster fertility treatments and reproductive health. With financial assistance and resources at their disposal, these initiatives aim to elevate technology and its success rates. Such unwavering support underscores the pivotal role of vitrification in advancing reproductive healthcare in APAC.